Edgewell Personal Care Company (EPC) is a publicly traded Consumer Defensive sector company. As of May 21, 2026, EPC trades at $17.13 with a market cap of $743.75M and a P/E ratio of 31.97. EPC moved +5.69% today. Year to date, EPC is +0.77%; over the trailing twelve months it is -40.29%. Its 52-week range spans $15.73 to $38.45. Analyst consensus is buy with an average price target of $25.20. Rallies surfaces EPC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Edgewell Q2 Net Sales Rise 0.6% to $519.5M, GAAP EPS Falls to $0.09: Edgewell reported Q2 fiscal 2026 net sales of $519.5 million, up 0.6% year-over-year, with organic net sales down 2.4% and GAAP EPS falling to $0.09 from $0.43. Adjusted EPS reached $0.60, and the company ended the quarter with $299.7 million in cash, declaring a $0.15 dividend.
| Metric | Value |
|---|---|
| Price | $17.13 |
| Market Cap | $743.75M |
| P/E Ratio | 31.97 |
| EPS | $0.53 |
| Dividend Yield | 0.15% |
| 52-Week High | $38.45 |
| 52-Week Low | $15.73 |
| Volume | 4 |
| Avg Volume | 0 |
| Revenue (TTM) | $2.22B |
| Net Income | $25.40M |
| Gross Margin | 41.60% |
5 analysts cover EPC: 0 strong buy, 3 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $25.20.